Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Moderna Inc MRNA

Healthcare Biotechnology
Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases, independently and with its strategic collaborators. mRNA medicines are designed to direct the body’s cells to produce intracellular... see more

Recent & Breaking News (NDAQ:MRNA)

MRNA DEADLINE ALERT: Bernstein Liebhard LLP Reminds Moderna, Inc. Investors of Upcoming Deadline

Accesswire August 29, 2024

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Moderna

Accesswire August 28, 2024

Investors in Moderna, Inc. Should Contact Levi & Korsinsky Before October 8, 2024 to Discuss Your Rights - MRNA

Accesswire August 28, 2024

Investors who lost money on Moderna, Inc.(MRNA) should contact Levi & Korsinsky about pending Class Action - MRNA

Accesswire August 28, 2024

The Schall Law Firm Urges Investors To Join A Securities Fraud Lawsuit Against Moderna Inc.

Accesswire August 28, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Moderna, Inc. of Class Action Lawsuit and Upcoming Deadlines - MRNA

Accesswire August 28, 2024

Moderna, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before October 8, 2024 to Discuss Your Rights - MRNA

Accesswire August 28, 2024

MRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud Lawsuit with the Schall Law Firm

PR Newswire August 28, 2024

MRNA LAWSUIT ALERT: Levi & Korsinsky Notifies Moderna, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

Accesswire August 28, 2024

MRNA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Moderna, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Accesswire August 28, 2024

October 8, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against MRNA

Accesswire August 27, 2024

ROSEN, A LEADING LAW FIRM, Encourages Moderna, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRNA

Newsfile August 27, 2024

Moderna, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before October 8, 2024 to Discuss Your Rights - MRNA

Accesswire August 27, 2024

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Moderna, Inc. (MRNA) Shareholders

Accesswire August 27, 2024

Moderna Is Being Sued For Possibly Violating Securities Regulations And Shareholders Are Invited To Participate

Accesswire August 27, 2024

Investors in Moderna, Inc. Should Contact Levi & Korsinsky Before October 8, 2024 to Discuss Your Rights - MRNA

Accesswire August 27, 2024

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Moderna

Newsfile August 27, 2024

MRNA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Moderna, Inc. Shareholders Have an Opportunity to Lead Class Action Lawsuit!

Accesswire August 27, 2024

Levi & Korsinsky Reminds Moderna, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 8, 2024 - MRNA

PR Newswire August 27, 2024

Moderna, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before October 8, 2024 to Discuss Your Rights - MRNA

Accesswire August 26, 2024